PitchBook named Goodwin as the most active firm globally and in the US for representing companies in M&A deals in its Q2 2026 Global League Tables. Goodwin was also named the top law firm by deal count for Pharma, Medical & Biotech M&A in Mergermarket M&A Deal Drivers (Americas and EMEA) League Tables. LSEG ranked Goodwin highly in several categories in its H1 2026 Global Venture Capital and Private Equity Legal Advisory League Tables.
These results underscore the strength of Goodwin’s global M&A practice and its long-term strategy of pairing sophisticated transactional capabilities with deep knowledge of the industries driving the global economy. Across its six core industry groups — healthcare, investment funds and capital, life sciences, private equity, real estate, and technology — the firm combines sector insight, legal excellence, and practical business judgment to help clients execute their most consequential transactions and achieve their most ambitious business goals.
Goodwin’s H1/Q2 2026 league table results include:
- PitchBook (by deal count)
- #1 M&A - Most active globally: companies
- #1 M&A - Most active in US: companies
- #2 Deals Overall - Europe
- #2 Private Equity - IT
- #2 Venture Capital - Pharma & BioTech
- #2 Venture Capital - Exits
- #3 Deals Overall - Global
- #3 Deals Overall - US
- #3 Venture Capital - Late stage
- #3 Venture Capital - Europe
- #3 Venture Capital - Energy
- #3 Venture Capital - IT hardware
- #4 M&A - US
- #4 Private Equity - US
- #4 Venture Capital - US
- #4 Venture Capital - Global
- #4 Venture Capital - Early stage
- #4 Venture Capital - HC services & systems
- #4 Venture Capital - Other
- #5 M&A - Global
- #5 Private Equity - Global
- #5 Private Equity - Healthcare
- #5 Private Equity - Other private equity deals
- #5 Venture Capital - Software
- #5 Venture Capital - Commercial products & services
- LSEG Global PE/VC (by deal count)
- #2 Advisor to Firm - All Private Equity Stages
- #2 Advisor to Firm - VC Rounds
- #3 Advisor to Company - LBO & Related Rounds
- #3 Advisor to Company - All Private Equity Stages
- #3 Advisor to Company - VC Rounds
- LSEG Global Capital Markets (by deal count)
- #2 US Equity & Equity-related (Issuer)
- Mergermarket M&A Deal Drivers (Americas)
- #1 Pharma, Medical & Biotech M&A (by deal count)
- #2 All Sectors: Mid-Market ($5m - $250m) M&A (by deal count and deal value)
- #2 Technology, Media & Telecom M&A (by deal count)
- #3 Real Estate M&A (by deal value)
- #4 All Sectors M&A (by deal count)
- Mergermarket M&A Deal Drivers (EMEA)
- #1 Pharma, Medical & Biotech M&A (by deal count)
- #3 All Sectors: Mid-Market (€5m - €250m) M&A (by deal count and deal value)
- #3 Technology, Media & Telecom M&A (by deal count)